The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2023Subtyping Parkinson’s Disease Using Genetic and Intestinal Inflammation Biomarkers
Study Rationale: Although Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, no drugs are currently available to treat or prevent the condition because the...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Targeting a Phospholipid Unique to Mitochondrial Membranes as a Therapeutic for Parkinson’s Disease
Study Rationale: Mitochondria are energy-generating structures vital to the health of all cells. In Parkinson’s disease (PD), mitochondrial dysfunction leads to neuronal degeneration and to the motor...
-
Circuits & Cellular Targets for PD’s Symptoms, 2023Unbiased Identification of New Targets for Deep Brain Stimulation to Treat Gait and Balance Impairments in Parkinson’s Disease
Study Rationale: Over time, people with Parkinson’s disease (PD) develop problems with their ability to walk that can cause serious injuries and curtail their independence. Mice with a particular...
-
Data-Driven Subtyping and Stratification Program, 2023Identifying Proteomic Biomarkers for Monitoring the Progression of Parkinson’s Pathophysiology
Study Rationale: Parkinson’s disease (PD) is often diagnosed at a stage where the disease has progressed significantly, restricting treatment options and limiting the opportunity to understand how the...
-
Circuits & Cellular Targets for PD’s Symptoms, 2023Pathophysiology of Neural Circuits Underlying Pain in Prodromal to Advanced Parkinson’s Disease
Study Rationale: Many people with Parkinson’s disease (PD) suffer from pain that is not managed well by existing therapies. We believe the ineffectiveness of these treatment strategies may be due to a...
-
Translational Pipeline Program, 2023Evaluating Use of a Spinal Cord Prosthesis to Alleviate Locomotor Deficits in Parkinson’s Disease
Study Rationale: Over the past two decades, we have developed a therapy that restores walking after paralysis due to a spinal cord injury. This therapy uses an implanted neurostimulation prosthesis to...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.